Immunic, Inc. ownership disclosure: Avidity Partners-related entities and Michael Gregory report shared beneficial ownership of 13,958,410 shares of Immunic common stock, representing 9.9% of the class.
The filing is a joint Schedule 13G listing the reporting persons, their Delaware/Cayman jurisdictions, shared voting and dispositive power over the same 13,958,410 shares, and a joint filing agreement. The signatures indicate Michael Gregory as managing member. The filing contains a disclaimer of beneficial ownership by each reporting person except for pecuniary interest.
Positive
None.
Negative
None.
Insights
Avidity reports a passive, large-position stake of 13,958,410 shares (9.9%).
The Schedule 13G lists Avidity Partners Management LP, related GP entities, Avidity Private Master Fund I LP and Michael Gregory as joint reporting persons, each shown with shared voting and dispositive power over 13,958,410 shares. The filing structure and signature block identify Michael Gregory as managing member for the reporting entities.
Filing text includes a disclaimer that each reporting person disclaims beneficial ownership except to the extent of pecuniary interest. Future Form 13D/Form 4 filings could alter the public ownership picture if the reporting group changes intent or engages in transactions.
Key Figures
Reported shares beneficially owned:13,958,410 sharesPercent of class:9.9%Form type / filing:Schedule 13G+1 more
4 metrics
Reported shares beneficially owned13,958,410 sharesAmount beneficially owned by each reporting person as listed in Item 4
Percent of class9.9%Percent of class corresponding to 13,958,410 shares as shown in Item 4
Form type / filingSchedule 13GJoint beneficial ownership disclosure for passive investors
CUSIP4525EP101CUSIP for Immunic common stock as reported in Item 1(d)/(e)
"joint Schedule 13G listing the reporting persons"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Immunic, Inc.
(Name of Issuer)
Common Stock, $0.0001 par value
(Title of Class of Securities)
4525EP101
(CUSIP Number)
02/17/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
4525EP101
1
Names of Reporting Persons
Avidity Partners Management LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
13,958,410.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
13,958,410.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
13,958,410.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.9 %
12
Type of Reporting Person (See Instructions)
IA, PN
SCHEDULE 13G
CUSIP Number(s):
4525EP101
1
Names of Reporting Persons
Avidity Partners Management (GP) LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
13,958,410.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
13,958,410.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
13,958,410.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.9 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
4525EP101
1
Names of Reporting Persons
Avidity Capital Partners Fund (GP) LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
13,958,410.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
13,958,410.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
13,958,410.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.9 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
4525EP101
1
Names of Reporting Persons
Avidity Capital Partners (GP) LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
13,958,410.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
13,958,410.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
13,958,410.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.9 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
4525EP101
1
Names of Reporting Persons
Avidity Private Master Fund I LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
13,958,410.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
13,958,410.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
13,958,410.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.9 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
4525EP101
1
Names of Reporting Persons
Michael Gregory
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
13,958,410.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
13,958,410.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
13,958,410.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.9 %
12
Type of Reporting Person (See Instructions)
HC, IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Immunic, Inc.
(b)
Address of issuer's principal executive offices:
1200 Avenue of the Americas, Suite 200, New York, NY 10036, USA
Item 2.
(a)
Name of person filing:
Avidity Partners Management LP
Avidity Partners Management (GP) LLC
Avidity Capital Partners Fund (GP) LP
Avidity Capital Partners (GP) LLC
Avidity Private Master Fund I LP
Michael Gregory
(b)
Address or principal business office or, if none, residence:
Avidity Partners Management LP
2828 N Harwood Street, Suite 1220
Dallas, Texas 75201
United States of America
Avidity Partners Management (GP) LLC
2828 N Harwood Street, Suite 1220
Dallas, Texas 75201
United States of America
Avidity Capital Partners Fund (GP) LP
2828 N Harwood Street, Suite 1220
Dallas, Texas 75201
United States of America
Avidity Capital Partners (GP) LLC
2828 N Harwood Street, Suite 1220
Dallas, Texas 75201
United States of America
Avidity Private Master Fund I LP
2828 N Harwood Street, Suite 1220
Dallas, Texas 75201
United States of America
Michael Gregory
c/o Avidity Partners Management LP
2828 N Harwood Street, Suite 1220
Dallas, Texas 75201
United States of America
(c)
Citizenship:
Avidity Partners Management LP - Delaware
Avidity Partners Management (GP) LLC - Delaware
Avidity Capital Partners Fund (GP) LP - Delaware
Avidity Capital Partners (GP) LLC - Delaware
Avidity Private Master Fund I LP - Cayman Islands
Michael Gregory - United States
(d)
Title of class of securities:
Common Stock, $0.0001 par value
(e)
CUSIP Number(s):
4525EP101
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Avidity Partners Management LP - 13,958,410
Avidity Partners Management (GP) LLC - 13,958,410
Avidity Capital Partners Fund (GP) LP - 13,958,410
Avidity Capital Partners (GP) LLC - 13,958,410
Avidity Private Master Fund I LP - 13,958,410
Michael Gregory - 13,958,410
(b)
Percent of class:
Avidity Partners Management LP - 9.9%
Avidity Partners Management (GP) LLC - 9.9%
Avidity Capital Partners Fund (GP) LP - 9.9%
Avidity Capital Partners (GP) LLC - 9.9%
Avidity Private Master Fund I LP - 9.9%
Michael Gregory - 9.9%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Avidity Partners Management LP - 0
Avidity Partners Management (GP) LLC - 0
Avidity Capital Partners Fund (GP) LP - 0
Avidity Capital Partners (GP) LLC - 0
Avidity Private Master Fund I LP - 0
Michael Gregory - 0
(ii) Shared power to vote or to direct the vote:
Avidity Partners Management LP - 13,958,410
Avidity Partners Management (GP) LLC - 13,958,410
Avidity Capital Partners Fund (GP) LP - 13,958,410
Avidity Capital Partners (GP) LLC - 13,958,410
Avidity Private Master Fund I LP - 13,958,410
Michael Gregory - 13,958,410
(iii) Sole power to dispose or to direct the disposition of:
Avidity Partners Management LP - 0
Avidity Partners Management (GP) LLC - 0
Avidity Capital Partners Fund (GP) LP - 0
Avidity Capital Partners (GP) LLC - 0
Avidity Private Master Fund I LP - 0
Michael Gregory - 0
(iv) Shared power to dispose or to direct the disposition of:
Avidity Partners Management LP - 13,958,410
Avidity Partners Management (GP) LLC - 13,958,410
Avidity Capital Partners Fund (GP) LP - 13,958,410
Avidity Capital Partners (GP) LLC - 13,958,410
Avidity Private Master Fund I LP - 13,958,410
Michael Gregory - 13,958,410
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
Please see Exhibit B attached hereto.
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Avidity Partners Management LP
Signature:
By: Avidity Partners Management (GP) LLC, its general partner, By: /s/ Michael Gregory
Name/Title:
Michael Gregory / Managing Member
Date:
04/17/2026
Avidity Partners Management (GP) LLC
Signature:
By: /s/ Michael Gregory
Name/Title:
Michael Gregory / Managing Member
Date:
04/17/2026
Avidity Capital Partners Fund (GP) LP
Signature:
By: Avidity Capital Partners (GP) LLC, its general partner, By: /s/ Michael Gregory
Name/Title:
Michael Gregory / Managing Member
Date:
04/17/2026
Avidity Capital Partners (GP) LLC
Signature:
By: /s/ Michael Gregory
Name/Title:
Michael Gregory / Managing Member
Date:
04/17/2026
Avidity Private Master Fund I LP
Signature:
By: Avidity Capital Partners Fund (GP) LP, its general partner, By: Avidity Capital Partners (GP) LLC, its general partner, By: /s/ Michael Gregory
Name/Title:
Michael Gregory / Managing Member
Date:
04/17/2026
Michael Gregory
Signature:
By: /s/ Michael Gregory
Name/Title:
Michael Gregory
Date:
04/17/2026
Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Exhibit Information
Exhibit A - Joint Filing Agreement
Exhibit B - Control Person Identification
What stake does Avidity Partners report in Immunic (IMUX)?
Avidity-related reporters and Michael Gregory report shared beneficial ownership of 13,958,410 shares, equal to 9.9% of Immunic's common stock. This is declared on a joint Schedule 13G filing with signatures dated in April 2026.
Who are the reporting entities listed for IMUX in this Schedule 13G?
The filing lists Avidity Partners Management LP, two Avidity GP entities, Avidity Private Master Fund I LP, and Michael Gregory. Addresses and citizenship (Delaware or Cayman Islands) are provided in the filing's Item 2.
Does the filing indicate who controls the voting or disposition of the shares?
The report shows 0 sole voting/dispositive power and 13,958,410 shared voting and shared dispositive power for each reporting person; the filing therefore attributes shared control among the listed entities.
Does the Schedule 13G state these holders admit beneficial ownership for Section 16 purposes?
No. The filing includes a signed disclaimer stating each reporting person disclaims beneficial ownership except to the extent of pecuniary interest, and that the report should not be deemed an admission of beneficial ownership for Section 16 or other purposes.
